| Code/trivial name (a) | IUPAC name/SMILES notation/InChiKey (b) | Structural formula (c) |
|---|---|---|
|
metribuzin, active substance, a.s., BCS‐AA51359 |
4‐amino‐6‐tert‐butyl‐3‐(methylthio)‐1,2,4‐triazin‐5(4H)‐one O=C1C(=NN=C(SC)N1N)C(C)(C)C FOXFZRUHNHCZPX‐UHFFFAOYSA‐N |
|
|
DA‐metribuzin, M01, desamino‐metribuzin, BCS‐AA91084 |
6‐tert‐butyl‐3‐(methylsulfanyl)‐1,2,4‐triazin‐5(4H)‐one CC(C)(C)C1=NN=C(SC)NC1=O MIWRSUQXSCLDNV‐UHFFFAOYSA‐N |
|
|
DK‐metribuzin, M02, diketo‐metribuzin, BCS‐AG59919 |
4‐amino‐6‐tert‐butyl‐1,2,4‐triazine‐3,5(2H,4H)‐dione O=C1N(N)C(=O)NN=C1C(C)(C)C AHBXXEZLRFCZSF‐UHFFFAOYSA‐N |
|
|
DADK‐metribuzin, M03, desaminodiketo‐metribuzin, BCS‐AA68848 |
6‐tert‐butyl‐1,2,4‐triazine‐3,5(2H,4H)‐dione O=C1NC(=O)NN=C1C(C)(C)C ZARIFGFXSIZTAK‐UHFFFAOYSA‐N |
|
|
t‐BuOH‐DADK‐metribuzin, M04, hydroxy‐t‐butyl‐DADK |
6‐(1‐hydroxy‐2‐methylpropan‐2‐yl)‐1,2,4‐triazine‐3,5(2H,4H)‐dione OCC(C)(C)C1=NNC(=O)NC1=O KPRRHPBFRZPBBH‐UHFFFAOYSA‐N |
|
|
4‐methyl‐DADK‐metribuzin, M17, BCS‐AA10228 |
6‐tert‐butyl‐4‐methyl‐1,2,4‐triazine‐3,5(2H,4H)‐dione O=C1N(C)C(=O)NN=C1C(C)(C)C HAMOEZWHUZLDGI‐UHFFFAOYSA‐N |
|
|
Desmethylthio‐metribuzin, M18, U1, BCS‐AA10033 |
4‐amino‐6‐tert‐butyl‐1,2,4‐triazin‐5(4H)‐one O=C1C(=NN=CN1N)C(C)(C)C GMHFNNALALGFKT‐UHFFFAOYSA‐N |
|
|
Sulfamate‐metribuzin, M15, Sulfamate‐conjugate #8, #8a, #8b |
[6‐tert‐butyl‐3‐(methylsulfanyl)‐5‐oxo‐1,2,4‐triazin‐4(5H)‐yl]sulfamic acid OS(=O)(=O)NN1C(=NN=C(C1=O)C(C)(C)C)SC CFTYOBVLLJEBCM‐UHFFFAOYSA‐N |
|
|
Butylthione‐metribuzin, M10, BCS‐AA66387 |
4‐amino‐6‐tert‐butyl‐3‐sulfanylidene‐3,4‐dihydro‐1,2,4‐triazin‐5(2H)‐one O=C1N(N)C(=S)NN=C1C(C)(C)C OFKAVNQBCRJBJE‐UHFFFAOYSA‐N |
Other tautomeric forms are possible (condition dependent) |
|
Cystein‐DA‐metribuzin, M12, Cystein‐DA, DA‐N‐Ac‐Cys |
N‐acetyl‐S‐(6‐tert‐butyl‐5‐oxo‐4,5‐dihydro‐1,2,4‐triazin‐3‐yl)cysteine CC(C)(C)C1=NN=C(SCC(NC(C)=O)C(=O)O)NC1=O NPYMOMKXKZUXGG‐UHFFFAOYSA‐N |
|
|
DK‐metribuzin glucuronide conjugate, M16, Glucuronide‐conjugate (of DK) #9 |
3‐[(6‐tert‐butyl‐3,5‐dioxo‐2,5‐dihydro‐1,2,4‐triazin‐4(3H)‐yl)amino]‐3‐deoxyhexopyranuronic acid OC1C(NN2C(=O)C(=NNC2=O)C(C)(C)C)C(O)C(OC1O)C(=O)O PDOLDXBUGCKOLV‐UHFFFAOYSA‐N |
|
The name in bold is the name used in the conclusion.
ACD/Name 2021.1.3 ACD/Labs 2021.1.3 (File Version N15E41, Build 123232, 07 July 2021).
ACD/ChemSketch 2021.1.3 ACD/Labs 2021.1.3 (File Version C25H41, Build 123835, 28 August 2021).
Other tautomeric forms are possible (condition dependent)